NOVOCART 3D
Commercial- Indications
- Cartilage repair
Company intelligence / Profile preview
Octane Medical Group
Kingston, Ontario, Canadaoctaneco.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Octane Medical Group has commercial products including NOVOCART 3D and NOVOCART Inject for articular cartilage repair, acquired from B. Braun. They also developed Octane HyperPEEK, an advanced biocomposite for bone regeneration.
- Therapeutic areas
- Rheumatology
- Modalities
- Cell TherapyBiomaterialsBioprocessesBioreactors
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
B. Braun (former partner)
Beyond the preview
Go deeper on Octane Medical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Octane Medical Group.